Canada’s Top 50 New Growth Companies: Aurora Cannabis (TSX:ACB) Places 6th

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) is facing serious challenges but this cannabis company with the largest production capacity will rule the global legal marijuana industry.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

A business website, canadianbusiness.com, came out with their list of Canada’s Top 50 New Growth Companies for 2019. The companies on the list represent the most promising companies Canada has to offer.

The common denominator of the Startup 50 is the success by which the companies brought innovative new ideas, products and services to market at a breakneck pace. And one company that has done it in style is Aurora Cannabis (TSX:ACB)(NYSE:ACB).

Rank No. 6

The choice of the Top 50 companies was meant to celebrate businesses that have achieved remarkable growth. The selection committee looked into the two-year revenue growth, and the company must have been founded and generating revenue between July 1, 2013 and early 2016. Aurora volunteered to participate.

Aurora Cannabis is the only cannabis producer that made it to the prestigious line up and its also the lone company that belongs to the agriculture industry. Aurora ranked 6th in terms of two-year revenue growth but had the highest revenue in 2018.

Its 3,735% 2-year revenue growth matches the growth of tech companies. But Aurora’s revenue range of $50 to $100 million in 2018 was the highest among the Top 50 companies.

The green rush

The legal marijuana industry is “greatest thing since the sliced bread” according to a market analyst, and for a good reason. The worldwide sales of legal marijuana tripled from 2014 to 2018, topping $10.9 billion. In the next 10 years, global sales could reach a staggering $200 billion by 2029 to 2030.

The cannabis space is losing its charm of late because of mounting losses, controversies and scandals. But the forthcoming Canadian Cannabis 2.0 market might revive investors’ interest.

The growth opportunity from the edibles market is also breathtaking, and annual sales could be in the vicinity of $2.7 billion.

According to Aurora Cannabis Chief Corporate Office Cam Battley, the company is developing cannabis-infused beverages with some hesitancy. Management thinks and anticipates “a relatively low market share of these products,” which is why the company is in no rush to enter the beverages market.

Aurora’s CEO Terry Booth sees the opportunity for organic edibles and sugar-free edibles. The plan is to introduce a variety of edibles products, including chocolates, mints, and hard baked goods.

Another terrific market segment is vape, although there’s growing concern about the harmful effects of vaping on health.

Biggest advantage

Aurora Cannabis still holds the biggest advantage in the cannabis industry – production capacity. Its Polaris facility is nearing completion by the end of 2019. Once completed, Aurora can ramp up production of high-margin derivative products including edibles in the 300,000 square foot facility.

Despite the current struggles of Aurora Cannabis, it’s a great Canadian cannabis company. If the industry should consolidate, it might very well be one of the prominent survivors.

In any case, market analysts maintain a bullish sentiment on the stock. Their forecast is a potential gain of 128% in the next 12 months.

From the looks of it, the analysts’ estimates are conservative. The massive production capacity of Aurora Cannabis will also give it the advantage if it boils down to a pricing war. Over the long run, Aurora Cannabis would be the top growth company in Canada.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »